Abstract
Viruslike particles often combine high physical stability with robust immunogenicity. Furthermore, when such particles are based on bacteriophages, they can be produced in high amounts at minimal cost and typically will require only standard biologically contained facilities. We provide protocols for the characterization and purification of recombinant viruslike particles derived from filamentous bacteriophages. As an example, we focus on filamentous Escherichia coli fd phage displaying a conserved influenza A virus epitope that is fused genetically to the N-terminus of the major coat protein of this phage. A step-by-step procedure to obtain a high-titer, pure recombinant phage preparation is provided. We also describe a quality control experiment based on a biological readout of the purified fd phage preparation. These protocols together with the highlighted critical steps may facilitate generic implementation of the provided procedures for the display of other epitopes by recombinant fd phages.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Clarke BE, Newton SE, Carroll AR, Francis MJ, Appleyard G, Syred AD, Highfield PE, Rowlands DJ, Brown F (1987) Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein. Nature 330:381–384
Smith GP, Petrenko VA (1997) Phage display. Chem Rev 97:391–410
Smith GP (1988) Filamentous phage assembly: morphogenetically defective mutants that do not kill the host. Virology 167:156–165
Sugimoto K, Sugisaki H, Okamoto T, Takanami M (1977) Studies on bacteriophage fd DNA IV. The sequence of messenger RNA for the major coat protein gene. J Mol Biol 111:487–507
Greenwood J, Hunter GJ, Perham RN (1991) Regulation of filamentous bacteriophage length by modification of electrostatic interactions between coat protein and DNA. J Mol Biol 217:223–227
Zhong G, Smith GP, Berry J, Brunham RC (1994) Conformational mimicry of a chlamydial neutralization epitope on filamentous phage. J Biol Chem 269:24183–24188
Zacher AN, Stock CA, Golden JW, Smith GP (1980) A new filamentous phage cloning vector: fd-tet. Gene 9:127–140
Smith GP, Fernandez AM (2004) Effect of DNA copy number on genetic stability of phage-displayed peptides. BioTechniques 36(4):610–614, 616, 618
Malik P, Terry TD, Gowda LR, Langara A, Petukhov SA, Symmons MF, Welsh LC, Marvin DA, Perham RN (1996) Role of capsid structure and membrane protein processing in determining the size and copy number of peptides displayed on the major coat protein of filamentous bacteriophage. J Mol Biol 260(1):9–21
De Berardinis P, Sartorius R, Fanutti C, Perham RN, Del Pozzo G, Guardiola J (2000) Phage display of peptide epitopes from HIV-1 elicits strong cytolytic responses. Nat Biotechnol 18:873–876
De Berardinis P, Sartorius R, Caivano A, Mascolo D, Domingo GJ, Del Pozzo G, Gaubin M, Perham RN, Piatier-Tonneau D, Guardiola J (2003) Use of fusion proteins and procaryotic display systems for delivery of HIV-1 antigens: development of novel vaccines for HIV-1 infection. Curr HIV Res 1:441–446
di Marzo VF, Willis AE, Boyer-Thompson C, Appella E, Perham RN (1994) Structural mimicry and enhanced immunogenicity of peptide epitopes displayed on filamentous bacteriophage. The V3 loop of HIV-1 gp120. J Mol Biol 243:167–172
De Berardinis P, D’Apice L, Prisco A, Ombra MN, Barba P, Del Pozzo G, Petukhov S, Malik P, Perham RN, Guardiola J (1999) Recognition of HIV-derived B and T cell epitopes displayed on filamentous phages. Vaccine 17:1434–1441
Frenkel D, Katz O, Solomon B (2000) Immunization against Alzheimer’s beta-amyloid plaques via EFRH phage administration. Proc Natl Acad Sci U S A 97:11455–11459
Deng L, Ibañez LI, Van den Bossche V, Roose K, Fiers W, Saelens X (2015) Protection against influenza A virus challenge with M2e-displaying filamentous E. coli phages. PLoS One 10(5):e0126650
Tzagoloff H, Pratt D (1964) The initial steps in infection with Coliphage M13. Virology 24:372–380
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Deng, L., Linero, F., Saelens, X. (2016). Production and Purification of Recombinant Filamentous Bacteriophages Displaying Immunogenic Heterologous Epitopes. In: Thomas, S. (eds) Vaccine Design. Methods in Molecular Biology, vol 1404. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-3389-1_31
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3389-1_31
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-3388-4
Online ISBN: 978-1-4939-3389-1
eBook Packages: Springer Protocols